ADVISORY BOARD
The Yale Healthcare Conference is proud and honored to be supported by our Advisory Board, a group of talented and accomplished luminaries in the healthcare and life sciences industry headed by our faculty advisor, Dr. Howard Forman.
Ramon Soto
Senior Vice President and Chief Marketing and Communications Officer
Northwell Health
Ramon Soto is a skilled marketing executive with deep healthcare and financial services experience. He has a demonstrated ability to create vision, establish long-term strategies and lead cross-functional teams. Mr. Soto has a proven track record of profitable growth in consumer, business-to-business and direct marketing. He is a passionate thought leader with strong analytic and Six Sigma quality skills.
​
Mr. Soto is the senior vice president, chief marketing and communications officer for Northwell Health. Mr. Soto is responsible for the development and execution of Northwell’s brand strategy, as well as for all aspects of marketing and communications, including public relations, digital engagement, strategic marketing, clinical marketing and customer acquisition.
​
Mr. Soto is a member of Northwell Health’s executive leadership, responsible for shaping the growth strategy and execution for the enterprise. Northwell Health is New York’s largest healthcare provider with a network of 22 hospitals, nearly 800 community and research facilities and 81,000 employees. With 5 million patient visits in 2018, Northwell Health is also one of the fastest-growing healthcare providers. Its market reach has expanded principally via acquisition of new hospitals, ambulatory facilities, physician practices and joint ventures.
​
Mr. Soto was formerly the chief marketing officer for Magellan Health, a healthcare services company focused on the unmet needs of individuals in the fast growing, highly complex and high cost areas of healthcare.
​
Prior to Magellan, Mr. Soto was a senior vice president with Aetna, managing the commercial marketing function for the Aetna enterprise. Mr. Soto ran the marketing function for Aetna’s national accounts, middle market, small group, specialty product and international business divisions, representing $32 billion in annual revenue.
Before his nine years at Aetna, Mr. Soto spent seven years at GE Capital. He had increasing levels of marketing responsibility in several GE Capital businesses, culminating in his executive leadership responsibilities as vice president of marketing and channel development for GE Capital Small Business Solutions.
​
In 2006, Mr. Soto was admitted into Yale School of Management’s MBA program for executives. He is also a graduate of GE Capital’s Leadership Interchange, a high potential manager training program. He is Six Sigma certified, was awarded a US government patent for co-development of GE Capital’s product development process and was an instructor at GE’s Small Business College.
​
Mr. Soto received his B.A. from the State University of New York at Binghamton in 1988.
Amy Woodrum is a Principal with Chartis. Her primary focus has been advising academic medical centers on strategic planning initiatives and developing advanced financial modeling to support strategic partnerships.
​
Amy's consulting experience includes enterprise strategic planning for a nationally ranked academic health system, partnership development between leading academic and community health systems, service line planning for a nationally recognized children’s hospital, partnership exploration between a rural hospital and community health system, and primary care strategy and workforce planning.
​
Prior to her work with Chartis, Amy served as a Program Associate with the Robert Wood Johnson Foundation (RWJF), the largest foundation in the United States dedicated solely to health. At RWJF, she oversaw a portfolio of grants exceeding $2.5M, facilitated the organization’s annual strategic assessment, and produced an annual impact scorecard.
​
In addition, Amy serves as a board member of the Yale Healthcare Conference.
Amy received her Master of Business Administration and her Master of Public Health, both from Yale University, and her Bachelor of Arts in Health & Society from the University of Pennsylvania.
Amy Woodrum
Principal
​
Dr. Greg Licholai
Chief Medical and Innovation Officer
Dr. Greg Licholai is Chief Medical and Innovation Officer at ICON plc, a global healthcare intelligence and clinical research organisation. He is on the faculty at Yale School of Management and is Co-Director of the Center for Digital Health. Previously, he was President of rare disease at Moderna Therapeutics, President and Chief Medical Officer at Castle Creek Pharmaceuticals, and partner at McKinsey & Co. where he ran the healthcare data service line. He was also a senior executive at Proteostasis, Amicus Therapeutics and Medtronic Neurological as well as venture investor for Domain Associates. He was co-founder of Immunome Therapeutics.
​
Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University and Boston College. He trained at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He serves on multiple company and non-profit boards including advisor to the Clinical Trials Transformation Initiative (CTTI), a public private partnership co-founded by Duke University and the Food and Drug Administration (FDA). He writes about innovation in healthcare for Forbes.
Ingrid M. Nembhard, Ph.D., M.S., is the Fishman Family President’s Distinguished Professor, Professor of Health Care Management, and Professor Management with a focus on Organizational Behavior at The Wharton School of the University of Pennsylvania. Prior to joining the faculty at The Wharton School, she was the Ira V. Hiscock Tenured Associate Professor at the Yale School of Public Health, Associate Professor at Yale School of Management, Associate Director of the Health Care Management Program at Yale, and Director of the Yale Training Program in Health Services Research.
Dr. Nembhard received her Ph.D. in Health Policy and Management, with a concentration in Organizational Behavior from Harvard University through a joint program between Harvard Business School and the Graduate School of Arts and Sciences. She received her M.S. in Health Policy and Management from Harvard University School of Public Health, and her B.A. in Ethics, Politics and Economics and in Psychology from Yale University.
Dr. Ingrid M. Nembhard
Clarion E. Johnson, MD
Clarion E. Johnson is the former global medical director of the Medicine and Occupational Health Department for ExxonMobil Corporation. The department delivers services to more than 88,000 ExxonMobil and affiliate employees worldwide. In addition to traditional work-related health services, the department delivers travel medicine to the many ExxonMobil employees who are engaged in exploration and production in a number of challenging environments in Africa, the CIS, China, and Southeast Asia.
Dr. Johnson is co-chair of the Planning Committee for the Forum on Public-Private Partnerships for Global Health and Safety at the National Academies of Sciences, Engineering, and Medicine. He has been a long time member of the Milbank Memorial Fund Board of Directors and has published numerous articles in various fields. Dr. Johnson is the 2012 recipient of the Society of Petroleum Engineers’ Health, Safety, Security, Environment, and Social Responsibility Award.
Dr. Johnson is board-certified in internal medicine, cardiology, and occupational medicine. He did his undergraduate work at Sarah Lawrence College and studied medicine at the Yale University School of Medicine.
Dr. Golding is a physician by training with investment experience in both the private and public markets. He currently manages the healthcare/life sciences portfolio for a large family office. Previously, he worked at Consonance Capital, a healthcare-only long/short public equity fund specializing in biopharmaceuticals, medical devices, diagnostics, and healthcare IT. Prior to joining Consonance, Dr. Golding worked in venture capital investing at F-Prime Capital Partners (formerly known as Fidelity Biosciences), a global venture capital firm specializing in biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services/IT. While at F-Prime, Dr. Golding was a Board Observer for Iora Health, an IT-enabled healthcare services company focused on building and operating de novo primary care practices. He was also a Board Observer for Symbiomix Therapeutics, a company focused on developing therapeutics in the area of women’s health (acquired by Lupin). Dr. Golding completed his training in Internal Medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School. He gained insight into the area of pharmaceutical regulation through an internship at the Food and Drug Administration in the Office of Regulatory Policy. He holds an MD from the Yale School of Medicine and an MBA from the Yale School of Management. He received a BA from the University of Pennsylvania, where he graduated summa cum laude.
Eric M. Golding, MD
Andrew Bhak
Andrew is Managing Director and Head of the Healthcare Investment Banking Group for BMO Capital Markets. Andrew has spent his entire 25-plus year career covering the Healthcare sector. He has served as advisor on more than $135 billion of M&A transactions, as well as debt and equity financings, for large and small companies, including CVS Health, Agiliti Health, Kindred Healthcare, GreatCall, Diplomat Pharmacy, Quest Diagnostics, Select Medical, and HCA Healthcare.
Andrew joined BMO from JP Morgan where he was a Managing Director in Healthcare Investment Banking. Prior to that, he served as Co-Head of Healthcare Services at Deutsche Bank and served in similar capacity at Morgan Stanley, where he helped build its healthcare services investment banking franchise.
Prior to his career as an investment banker, Andrew was a senior equity research analyst responsible for coverage of the healthcare provider and services sector. Andrew also serves as a Visiting Scholar at the Yale School of Management, on the Leadership Council for the Dean of the Yale School of Public Health, and on the Advisory Board for the Yale Healthcare.
Andrew attended Yale University for his M.P.H. and received his B.G.S. from Kent State University.
Robert Galvin, MD, is CEO of The Right Doctor which connects people with serious illnesses to expert physicians and centers of excellence. He is also a Senior Advisor at Blackstone, where he was an Operating Partner and CEO of Equity Healthcare, a $2B health management company, from 2010-2022. Prior to Blackstone, he was a Senior Executive at GE, managing their $3B annual employee health spend and 220 global medical clinics while also serving as Chief Medical Officer.
Dr Galvin is one of the founders of value-based purchasing and has started three non-profits supporting quality measurement and payment reform: the Leapfrog Group (co-founder), Prometheus, and Catalyst for Payment Reform (CPR). His policy work has been published in the New England Journal of Medicine, the Harvard Business Review and Health Affairs. He is a member of the National Academy of Medicine and Professor Adjunct of Medicine and Health Policy at Yale.
Currently, he is Chair of the Board of CPR and a board member and committee chair of the Special Olympics of Connecticut and the Institute for Exceptional Care, both non-profits focused on people with intellectual disability. He is the medical advisor for the American Ballet Theater.
He also sits on the boards of several for-profits, including Team Health, a provider staffing company, Paige AI, a digital pathology firm, Real Endpoints, which is focused on value in pharmaceuticals and XO Health, a start-up health plan.
Dr. Galvin was a recipient of the John D. Thompson award from the Yale School of Public Health and has received recognition for his work from the National Business Group on Health, Healthcare Financial Management Association, and the National Coalition for Cancer Survivorship. He was recently recognized as a “Hero of the American Ballet Theatre” and elected to the Special Olympics of Connecticut Hall of Fame for his work on COVID-19.
Robert Galvin, MD, MBA
Pranav Abraham, PhD
Pranav Abraham leads Medical Evidence Strategy for Sanofi's Global Medical Affairs Rare Diseases team. He has deep expertise in using digital health technologies to capture patient outcomes, develop novel endpoints, and leverage healthcare data for generating innovative real-world evidence to inform regulatory, payer, and clinical decision-making. Prior to Sanofi, Pranav headed the global health economics strategy for several oncology and hematology indications at Bristol Myers Squibb. He holds a Ph.D. in Pharmaceutical Economics and Policy from the Massachusetts College of Pharmacy and Health Sciences in Boston and is currently a first-year student in the MBA For Executives program at Yale SOM.
He is passionate about driving the adoption of digital health technologies, AI/ML techniques, and data analytics in routine clinical practice, along with advising new ventures in this space.
Margaret Alabi is the US and Global Dermatology Patient Advocacy Director with Regeneron Pharmaceuticals. Margaret is passionate about healthcare and personal development and brings a wealth of experience and valuable skills to our team.
Originally from Atlanta, Margaret earned her Doctor of Pharmacy degree from Xavier University of Louisiana, College of Pharmacy. She has spent the past twelve years working in various areas of the pharmaceutical industry, gaining expertise in commercial, medical, and corporate affairs. Margaret has a proven track record of taking on increasing responsibilities and is well-versed in the industry's operations.
Margaret enjoys pursuing her interests outside of work, including Brazilian Jiu-Jitsu, a mentally and physically challenging sport. Additionally, Margaret is a Professional Certified Executive Coach (PCC) and employs her expertise to assist individuals in achieving their personal and professional goals, overcoming challenges, and growing as individuals.
She volunteers with the C5 Leadership program, mentoring middle and high school students to develop leadership skills. Margaret is a proud fur parent to three standard poodles named Belle, Beau, and Banksy. Ask her about her furry companions, and you'll surely see a smile on her face!
​
Margaret's diverse background, enthusiasm, and commitment to personal growth make her an excellent addition to our team. We warmly welcome her as she embarks on this exciting journey with us.
